Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 91 clinical trials
Trial T2 User Test Test1234 (fdg)  

dfgfdg

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (5.2 away)
  • 0 views
  • 24 Apr, 2024
  • 1 location
change - Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis (TOP-N53-02)  

change - The main goal of this clinical trial is to learn about how safe the new drug TOP-N53 solution is when it is applied to open wounds on the fingertip (digital ulcers) in people with an uncommon illness that results in hard, thickened areas of skin and additional problems …

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (5.2 away)
  • 0 views
  • 13 Jun, 2025
  • +2 other locations
Test Trial v7.4  

Test Trial v7.4

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (5.2 away)
  • 0 views
  • 24 Mar, 2026
  • 1 location
Regression testing of PS ( DO NOT TOUCH )  

Regression testing of PS ( DO NOT TOUCH )

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (5.2 away)
  • 0 views
  • 25 Mar, 2026
  • 1 location
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

Background People with rare cancers often have limited treatment options. The biology of rare cancers is not well understood. Researchers want to find better treatments for these cancers. They want to test 2 drugs that, taken separately, have helped people with non-rare cancers. They want to see if these drugs …

pheochromocytoma, malignant
nitrosoureas
squamous cell carcinoma
cavities
cholangiocarcinoma
National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Assessing the Sensitivity of "SureTouch " in Identifying Clinically Significant Masses in Women Undergoing Diagnostic and Screening Mammography

Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

screening mammography
George Washington University - Medical Faculty Associates
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study Evaluating JUV DERM VOLUMA XC Injectable Gel for Correction of Temple Hollowing in Adult Participants Over 22 Years Old

The objectives of this study are to evaluate the safety and effectiveness of Juvederm Voluma XC injectable gel in adult participants seeking correction of temple hollowing

Callender Center for Clinical Research
 (7.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +14 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
tirzepatide
cardiovascular disease
dulaglutide
MedStar Health Research Institute
 (1.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
mini-mental state examination
positron emission tomography
flortaucipir
alzheimer's disease
Georgetown University Medical Center
 (8.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

headache
ly573144
migraine
preventive medication
lasmiditan
Children's National Medical Center
 (5.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations